HFS
NVAX icon

Hantz Financial Services’s Novavax NVAX Stock Holding History

Hantz Financial Services’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Sell
63
-386
-86% -$3.46K ﹤0.01% 2400
2026
Q1 		$4K Buy
449
+400
+816% +$3.63K ﹤0.01% 2222
2025
Q4 		$0 Hold
49
– – ﹤0.01% 2498
2025
Q3 		$0 Sell
49
-15
-23% -$117 ﹤0.01% 2415
2025
Q2 		$0 Hold
64
– – ﹤0.01% 2265
2025
Q1 		$0 Hold
64
– – ﹤0.01% 1895
2024
Q4 		$1K Hold
64
– – ﹤0.01% 1048
2024
Q3 		$1K Hold
64
– – ﹤0.01% 1032
2024
Q2 		$1K Sell
64
-6
-9% -$60 ﹤0.01% 1012
2024
Q1 		$0 Sell
70
-262
-79% -$1.22K ﹤0.01% 1270
2023
Q4 		$2K Hold
332
– – ﹤0.01% 1035
2023
Q3 		$2K Buy
332
+10
+3% +$80 ﹤0.01% 1028
2023
Q2 		$2K Hold
322
– – ﹤0.01% 996
2023
Q1 		$2K Buy
322
+5
+2% +$46 ﹤0.01% 1005
2022
Q4 		$3K Hold
317
– – ﹤0.01% 933
2022
Q3 		$6K Buy
317
+86
+37% +$3.73K ﹤0.01% 823
2022
Q2 		$12K Buy
231
+50
+28% +$2.59K ﹤0.01% 720
2022
Q1 		$13K Buy
181
+95
+110% +$8.47K ﹤0.01% 754
2021
Q4 		$12K Buy
+86
New +$14.8K ﹤0.01% 681

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Hantz Financial Services's NVAX Position: Q2 2026 in Review

Hantz Financial Services reduced its Novavax (NVAX) stake by 86% in Q2 2026, selling an estimated $3.46K and leaving 63 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2400.

Hantz Financial Services first reported a position in NVAX in Q4 2021 and has held it in 19 quarters since. The position peaked at $13K in Q1 2022. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Hantz Financial Services held 63 shares of Novavax worth $1K as of Q2 2026.
  • Hantz Financial Services sold 386 Novavax shares in Q2 2026, an estimated $3.46K.
  • Novavax made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #2400 holding.
  • Hantz Financial Services first reported a position in Novavax in Q4 2021 and has held it in 19 quarters since.
  • Hantz Financial Services's Novavax position peaked at $13K in Q1 2022.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.